Citation: Hj. Avenarius, REVIEW - THE UNCERTAINTY OF THE PROGNOSIS DURING THE CONSULTATION - CLARIFICATION FOR ESTABLISHING A DIAGNOSIS, Medizinische Klinik, 91, 1996, pp. 93-96
Authors:
KADAR JG
ARSENIEV L
SOSADA M
AVENARIUS HJ
SCHNITTGER K
DIEDRICH H
SUDMEIER I
ZAKI M
BATTMER K
STANGEL W
LINK H
Citation: Jg. Kadar et al., PROSPECTIVE-STUDY OF DONOR SAFETY IN GROWTH-FACTOR MOBILIZATION AND PROGENITOR-CELL APHERESIS FOR ALLOGENEIC TRANSPLANTATION, Blood, 86(10), 1995, pp. 2304-2304
Authors:
BALLMAIER M
SCHULZE H
AVENARIUS HJ
WELTE K
Citation: M. Ballmaier et al., MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR (MGDF) SYNERGIZES WITH ADP AND THROMBIN RECEPTOR AGONISTS TO ACTIVATE PLATELETS, Blood, 86(10), 1995, pp. 3562-3562
Authors:
RANKE C
CREUTZIG A
LUSKA G
WAGNER HH
GALANSKI M
BODEBOGER S
FROLICH J
AVENARIUS HJ
HECKER H
ALEXANDER K
Citation: C. Ranke et al., CONTROLLED TRIAL OF HIGH-VERSUS LOW-DOSE ASPIRIN TREATMENT AFTER PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY IN PATIENTS WITH PERIPHERAL VASCULAR-DISEASE, The Clinical investigator, 72(9), 1994, pp. 673-680
Authors:
AVENARIUS HJ
FREUND M
KLEINE HD
HEUSSNER P
POLIWODA H
Citation: Hj. Avenarius et al., GRANULOCYTE-COLONY-STIMULATING FACTOR ENHANCES THE EXPRESSION OF CD62ON PLATELETS IN-VIVO, International journal of hematology, 58(3), 1993, pp. 189-196
Authors:
RANKE C
CREUTZIG A
LUSKA G
WAGNER HH
GALANSKI M
BODEBOGER S
FROLICH J
AVENARIUS HJ
HECKER H
ALEXANDER K
Citation: C. Ranke et al., DOSE-DEPENDENT ADVERSE-EFFECTS OF ASPIRIN TREATMENT IN PATIENTS WITH PERIPHERAL ARTERIAL OCCLUSIVE DISEASE - RESULTS OF A CONTROLLED CLINICAL-TRIAL, Medizinische Klinik, 88(10), 1993, pp. 571-576
Authors:
HOPER MM
SOSADA M
WAGNER TOF
BARTHELS M
AVENARIUS HJ
POLIWODA H
FABEL H
Citation: Mm. Hoper et al., INCREASED PLASMA ACTIVITY OF PLASMINOGEN-ACTIVATOR INHIBITOR IN PATIENTS WITH PRIMARY PULMONARY-HYPERTENSION, The American review of respiratory disease, 147(4), 1993, pp. 534-534